2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy
Published 9 May 2019
Jeffrey A. Towbin, MS, MD; William J. McKenna, MD, DSc; Dominic J. Abrams, MD, MRCP, MBA; Michael J. Ackerman, MD, PhD; Hugh Calkins, MD, FHRS, CCDS; Francisco C.C. Darrieux, MD, PhD; James P. Daubert, MD, FHRS; Christian de Chillou, MD, PhD; Eugene C. DePasquale, MD; Milind Y. Desai, MD; N.A. Mark Estes III, MD, FHRS, CCDS; Wei Hua, MD, FHRS; Julia H. Indik, MD, PhD, FHRS; Jodie Ingles, MPH, PhD, FHRS; Cynthia A. James, ScM, PhD, CGC; Roy M. John, MBBS, PhD, CCDS, FHRS; Daniel P. Judge, MD; Roberto Keegan, MD; Andrew D. Krahn, MD, FHRS; Mark S. Link, MD, FHRS; Frank I. Marcus, MD; Christopher J. McLeod, MBChB, PhD, FHRS; Luisa Mestroni, MD; Silvia G. Priori, MD, PhD; Jeffrey E. Saffitz, MD, PhD; Shubhayan Sanatani, MD, FHRS, CCDS; Wataru Shimizu, MD, PhD; J. Peter van Tintelen, MD, PhD; Arthur A.M. Wilde, MD, PhD; Wojciech Zareba, MD, PhD
Heart Rhythm. 2019 Nov;16(11):e301-72
Arrhythmogenic cardiomyopathy (ACM) is an arrhythmogenic disorder of the myocardium not secondary to ischemic, hypertensive, or valvular heart disease. ACM incorporates a broad spectrum of genetic, systemic, infectious, and inflammatory disorders. This designation includes, but is not limited to, arrhythmogenic right/left ventricular cardiomyopathy, cardiac amyloidosis, sarcoidosis, Chagas disease, and left ventricular noncompaction. The ACM phenotype overlaps with other cardiomyopathies, particularly dilated cardiomyopathy with arrhythmia presentation that may be associated with ventricular dilatation and/or impaired systolic function
This international consensus statement from the Heart Rhythm Society (HRS) is intended to help cardiologists and other health care professionals involved in the care of adult and pediatric patients with arrhythmogenic cardiomyopathy (ACM), which encompasses a broad range of disorders, by providing recommendations for evaluation and management and supporting shared decision making between health care providers and patients in a document format that is also useful at the point of care.
Read at Heart RhythmRelated Guidlines
-
ISHLT Working Formulation of a Standardized Nomenclature for Cardiac Allograft Vasculopathy—2010
-
Utilization of Hepatitis C Virus–Infected Organ Donors in Cardiothoracic Transplantation
-
Chronic Lung Allograft Dysfunction: Definition and Update of Restrictive Allograft Syndrome
-
ISHLT Consensus Statement for the Standardization of Bronchoalveolar Lavage in Lung Transplantation
-
Consensus Statements from the ISHLT Consensus Conference: Heart Failure Related Cardiogenic Shock